Revisiting Natural Capsules: Is It Worth the Risk Now?

The current state of Natural Capsules' stock, its core fundamentals, and its valuation; insights for potential investors to make an informed decision. Briefing Since peaking at ₹638.95 per share on 9 Sep. 2022, the stock of Natural Capsules has been in a long decline during which it lost 50 per cent in value over one-and-half … Continue reading Revisiting Natural Capsules: Is It Worth the Risk Now?

How to Beat the Market

Identify High-Risk Stocks That Are More Likely to Get Re-Rated, and for that, Focus on Core Fundamentals. “In the short run, the market is a voting machine. In the long run, it is a weighing machine.” Benjamin Graham “Beating the Market”: earning an investment return greater than the return of benchmark indices such as Sensex, … Continue reading How to Beat the Market

Is Ador Fontech Stock a Buy or Sell?

Analysing ADFL's Financials and Valuation to Determine its Investment Prospects The stock of Ador Fontech trades at ₹140 per share – 11 per cent off its all-time high of ₹157.20 per share attained on 5 Jan. 2024. The stock has delivered superior returns over the past five years – 21.16 per cent annually. On a … Continue reading Is Ador Fontech Stock a Buy or Sell?

Gandhi Special Tubes: No Tailwinds, No Headwinds Either

"Examining the Risks and Rewards of Investing in the Stock of a Niche Manufacturing Company" Firstly, for the benefit of the uninitiated, a brief introduction to the stock: Gandhi Special Tubes principally manufactures a niche product – small-diameter seamless steel tubes that are supplied to the original equipment manufacturers (OEMs) in the automotive, farm equipment, … Continue reading Gandhi Special Tubes: No Tailwinds, No Headwinds Either

Star Cement: Is it Worth Investing Now?

Scrutinising Star Cement's Recent Outstanding Performance, Current Valuation, and Investment Prospects The stock of Star Cement gained 10.54 per cent on 22 Mar. 2024 – and closed the day at ₹232 per share – making a new all-time high. The stock now trades at ₹230.60 per share. One-and-a-half years ago, in Sep. 2022, it was … Continue reading Star Cement: Is it Worth Investing Now?

Asset Bubbles: How to Recognize One?

Recognizing Asset Bubbles – preferably before they burst – from Economic Behavioural Changes They Breed. Asset bubbles are formed by the rapid rise in asset prices, far outrunning the asset's fundamentals. Sudden wealth gained through such rapid rise in asset prices initiates marked changes in the economic behaviour of its acquirer: those who were active … Continue reading Asset Bubbles: How to Recognize One?

Significance of Interpreting Market Price Action

For successful investing… the market price movement should be given the most consideration… often greater than fundamentals and valuation… The phrase ‘market prices reflect everything’ means that, at any moment, a stock’s price reflects all information concerning its business prospect – and every price change then on reflects a change in those prospects. However, this … Continue reading Significance of Interpreting Market Price Action

L G Balakrishnan, Oriental Carbon, Associated Alcohols

This post discusses the investment prospects of L G Balakrishnan & Bros., Oriental Carbon & Chemicals, and Associated Alcohols & Breweries. Convergence The Past One-year Performance of L G Balakrishnan & Bros. illustrates the Importance of Margin of Safety in Stock Investing In April 2023, when we previously discussed it, we were bullish on the … Continue reading L G Balakrishnan, Oriental Carbon, Associated Alcohols

Stock Musings – Lincoln Pharma, Dynemic Products, Pakka

LINCOLN PHARMA The stock of Lincoln Pharma is up 90 percent in the last year, a commendable feat considering its low earnings growth, mediocre working capital management, and sluggish capital allocation. However, it is not a poor-quality stock. The stock has good fundamentals, such as a debt-free balance sheet and a high and stable gross … Continue reading Stock Musings – Lincoln Pharma, Dynemic Products, Pakka

Analysis: Q3FY24 Results – II

This post discusses the financial performance of Meghmani Organics, RACL Geartech, and Kovai Medical Center & Hospital for the quarter ended 31 Dec. 2023 and their investment prospects considering these results. Meghmani Organics Meghmani Organics (MOL) reported its Q3FY24 (quarter ended 31 Dec. 2023) results on Jan. 30, 2024. This quarter's financial performance is a … Continue reading Analysis: Q3FY24 Results – II